<ARTICLE> 5 <CIK> 0000942788 <NAME> NEOPHARM, INC. <PERIOD-TYPE> YEAR <FISCAL-YEAR-END> DEC-31-1995 <PERIOD-START> JAN-01-1995 <PERIOD-END> DEC-31-1995 <CASH> 671 <SECURITIES> 0 <RECEIVABLES> 0 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 671 <PP&E> 29,332 <DEPRECIATION> 20,548 <TOTAL-ASSETS> 495,891 <CURRENT-LIABILITIES> 4,553,728 <BONDS> 303,555 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 1,008 <OTHER-SE> (4,362,400) <TOTAL-LIABILITY-AND-EQUITY> (4,361,392) <SALES> 0 <TOTAL-REVENUES> 0 <CGS> 0 <TOTAL-COSTS> 0 <OTHER-EXPENSES> 1,313,584 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 356,043 <INCOME-PRETAX> (1,669,627) <INCOME-TAX> 0 <INCOME-CONTINUING> (1,669,627) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (1,669,627) <EPS-PRIMARY> (0.57) <EPS-DILUTED> 0